Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram in mild Huntington's disease
NCT00271596Phase 2Completed
- Sponsor
- University of Iowa
- Start
- Nov 2005
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of citalopram in Huntington's disease (HD), sponsored by University of Iowa. Primary endpoint: Executive Function Composite Score at 15 weeks. Started Nov 2005; status: completed.
02
Drugs
citalopram
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00271596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271596.